Handelsbanken Fonder’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50.7M | Buy |
155,362
+38,679
| +33% | +$12.6M | 0.18% | 112 |
|
|
2025
Q1 | $31.5M | Buy |
116,683
+62,337
| +115% | +$16.8M | 0.13% | 155 |
|
|
2024
Q4 | $12.8M | Sell |
54,346
-18,835
| -26% | -$4.43M | 0.05% | 322 |
|
|
2024
Q3 | $20.1M | Buy |
73,181
+130
| +0.2% | +$35.8K | 0.08% | 230 |
|
|
2024
Q2 | $17.8M | Sell |
73,051
-2,055
| -3% | -$499K | 0.08% | 228 |
|
|
2024
Q1 | $11.2M | Buy |
75,106
+208
| +0.3% | +$31.1K | 0.05% | 332 |
|
|
2023
Q4 | $14.3M | Sell |
74,898
-94,845
| -56% | -$18.2M | 0.07% | 265 |
|
|
2023
Q3 | $30.1M | Buy |
169,743
+99
| +0.1% | +$17.5K | 0.17% | 138 |
|
|
2023
Q2 | $32.2M | Sell |
169,644
-1,645
| -1% | -$312K | 0.17% | 135 |
|
|
2023
Q1 | $34.3M | Sell |
171,289
-21,005
| -11% | -$4.21M | 0.2% | 120 |
|
|
2022
Q4 | $45.7M | Buy |
192,294
+64,701
| +51% | +$15.4M | 0.29% | 81 |
|
|
2022
Q3 | $25.5M | Sell |
127,593
-44,407
| -26% | -$8.89M | 0.17% | 149 |
|
|
2022
Q2 | $25.1M | Buy |
172,000
+600
| +0.4% | +$87.5K | 0.16% | 147 |
|
|
2022
Q1 | $28M | Sell |
171,400
-16,400
| -9% | -$2.68M | 0.16% | 148 |
|
|
2021
Q4 | $31.8M | Buy |
187,800
+167,700
| +834% | +$28.4M | 0.16% | 147 |
|
|
2021
Q3 | $3.8M | Buy |
20,100
+1,000
| +5% | +$189K | 0.02% | 515 |
|
|
2021
Q2 | $3.24M | Sell |
19,100
-1,200
| -6% | -$203K | 0.02% | 544 |
|
|
2021
Q1 | $2.87M | Sell |
20,300
-1,400
| -6% | -$198K | 0.02% | 539 |
|
|
2020
Q4 | $2.82M | Buy |
21,700
+2,500
| +13% | +$325K | 0.02% | 531 |
|
|
2020
Q3 | $2.8M | Hold |
19,200
| – | – | 0.02% | 486 |
|
|
2020
Q2 | $2.84M | Buy |
+19,200
| New | +$2.84M | 0.02% | 451 |
|
|
2016
Q1 | – | Sell |
-6,348
| Closed | -$598K | – | 249 |
|
|
2015
Q4 | $598K | Buy |
+6,348
| New | +$598K | 0.01% | 600 |
|